Stay updated on Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The Study Protocol and Statistical Analysis Plan document revision was updated from v3.6.3 to v3.6.4, indicating a newer version is now available.
    Difference
    0.1%
    Check dated 2026-07-26T18:57:05.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.2 to v3.6.3, indicating a small update to the document or template rather than a change to trial information.
    Difference
    0.1%
    Check dated 2026-07-05T04:46:12.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.2, replacing the previous v3.6.0 and indicating a refreshed page version.
    Difference
    0.1%
    Check dated 2026-06-28T00:20:52.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Recruitment status on the study page was updated to indicate that no more participants are being sought. At the same time, the page adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and logs a new Revision: v3.6.0, while older labels such as Intervention / Treatment and Revision: v3.5.5 were removed.
    Difference
    0.5%
    Check dated 2026-06-13T17:09:42.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.4 to v3.5.5, indicating a minor backend or UI update without changing the study details.
    Difference
    0.1%
    Check dated 2026-06-06T14:06:30.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.4 instead of v3.5.3, representing a newer version of the record and a metadata refresh rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T05:57:42.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Metastatic NSCLC Clinical Trial page.